Bio-Rad Laboratories | BIO - Market Capitalization


Bio-Rad Laboratories reported $8.89B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 181.89B 10.88B Oct/2026
Agilent USD 39.08B 6.43B Jun/2026
Becton, Dickinson and Co. USD 41.7B 3.07B Jun/2026
Bio-Rad Laboratories USD 7.87B 390M Jun/2026
Bruker USD 9.16B 3.66B Jun/2026
Charles River Laboratories USD 10.39B 2.54B Jun/2026
Danaher USD 168.91B 11.1B Oct/2026
General Electric Aerospace USD 313.36B 10.66B Oct/2026
Illumina USD 45.45B 18.74B Oct/2026
IQVIA Holdings USD 49.29B 5.03B Oct/2026
Laboratory Of America USD 30.3B 5.31B Oct/2026
Merck USD 372.93B 55.56B Oct/2026
Mettler Toledo International USD 25.82B 278M Jun/2026
OraSure Technologies USD 174M 61M Dec/2025
Pacific Biosciences Of California USD 565M 180M Dec/2025
Quest Diagnostics USD 27.15B 1.43B Oct/2026
Repligen USD 9.81B 1.04B Oct/2026
Revvity USD 12.69B 2.75B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Siemens EUR 219.86B 59B Jun/2026
Standard Biotools USD 359M 133M Mar/2026
Thermo Fisher Scientific USD 264.64B 15.06B Oct/2026
Tosoh JPY 951.51B 199.44B Jun/2026
Waters USD 37.24B 7.38B Jun/2026